Senti Biosciences Holdings SNTI
Senti Biosciences Holdings holds 2026 Annual Meeting
- Form
- 8-K
- Filed
- Importance
- Major
- Accession
- 0001628280-26-065992
- 20,240,055 shares voted, 64.98% of total
- Three new directors elected: Timothy Lu, Edward Mathers, Frances Schulz
- KPMG ratified as auditors for 2026
- Merger agreement approved with 15,851,146 votes for
Written from the 8-K on EDGAR. Check the filing before you rely on it.
Similar companies
Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.
- Avalo Therapeutics AVTX public float $54M, Jun 30, 2025
- Cue Biopharma CUE public float $52M, Jun 30, 2025
- Fitlife Brands FTLF public float $51M, Jun 30, 2025
- Immucell ICCC public float $51M, Jun 30, 2025
- iBio IBIO public float $58M, Dec 31, 2025